Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | AGXT | P21549 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4074881 | 0.91 | ESR1 (0.50) | CYP2A6CYP1A2AGXTTDP1KDM4E | |
| SCHEMBL2510402 | 0.82 | ESR1 (0.55) | CYP2A6CYP1A2AGXTKDM4ECA1 | |
| SCHEMBL3684663 | 0.82 | ESR1 (0.55) | CYP2A6CYP1A2AGXTKDM4ECA1 | |
| SCHEMBL3437809 | 0.81 | CYP1A2 (0.52) | CYP2A6CYP1A2AGXTTDP1KDM4E | |
| SCHEMBL3422941 | 0.81 | ESR1 (0.52) | CYP1A2CA1CA2CA9ALOX5 | |
| SCHEMBL3689307 | 0.79 | HSD17B1 (0.53) | CYP1A2KDM4ECA1CA2CA9 | |
| SCHEMBL3500443 | 0.78 | CYP2A6 (0.67) | CYP2A6CYP1A2AGXTTDP1KDM4E | |
| SCHEMBL1403727 | 0.78 | CYP1A2 (0.60) | CYP2A6CYP1A2KDM4EMAPK1CA1 | |
| SCHEMBL1274301 | 0.76 | CYP1A2 (0.50) | CYP1A2TDP1MAPTMEN1KMT2A | |
| SCHEMBL16241396 | 0.76 | ALDH1A1 (0.50) | CYP2A6CYP1A2AGXTTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11905237-B2 | Access to chiral bisphenol (BPOL) ligands through desymmetrizing asymmetric ortho-selective mono-halogenation | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2024-02-20 | — | — | US | claimed |
| US-20210300853-A1 | ACCESS TO CHIRAL BISPHENOL (BPOL) LIGANDS THROUGH DESYMMETRIZING ASYMMETRIC ORTHO-SELECTIVE MONO-HALOGENATION | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2021-09-30 | — | — | US | claimed |
| US-8921299-B2 | Detergents having acceptable color | THE PROCTER & GAMBLE COMPANY (US) | 2014-12-30 | — | — | US | claimed |
| US-20070274922-A1 | Water Soluble Boronic Acid Fluorescent Reporter Compounds and Methods of Use Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-11-29 | — | — | US | claimed |
| WO-2005024416-A1 | WATER SOLUBLE BORONIC ACID FLUORESCENT REPORTER COMPOUNDS AND METHODS OF USE THEREOF | WANG BINGHE (US) | 2005-03-17 | — | — | WO | claimed |
| US-12522813-B2 | Mannanase for formulations having pH 5-12 | BASF SE (DE) | 2026-01-13 | — | — | US | disclosed |
| EP-4148049-B1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING ORGANIC LIGHT-EMITTING COMPOUND | SFC CO LTD (KR) | 2025-11-12 | — | — | EP | disclosed |
| US-12441713-B2 | Organic compound and organic electroluminescent device comprising the same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2025-10-14 | — | — | US | disclosed |
| US-12435128-B2 | Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1 | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2025-10-07 | — | — | US | disclosed |
| US-20250311628-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2025-10-02 | — | — | US | disclosed |
| US-12389794-B2 | Plurality of host materials and organic electroluminescent device comprising the same | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2025-08-12 | — | — | US | disclosed |
| US-20250185453-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2025-06-05 | — | — | US | disclosed |
| US-6114361-A | INHIBITORS OF MATRIX METALLOPROTEINASES AND REPROLYSIN; ADMINISTERING TO TREAT CONDITIONS WHICH CAN BE TREATED BY THE INHIBITION OF THESE ENZYMES | PFIZER INC. (US) | 2000-09-05 | — | — | US | disclosed |
| EP-1004578-A2 | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives | Pfizer Products Inc. (US) | 2000-05-31 | — | — | EP | disclosed |
| WO-2000028331-A1 | USE OF RADIOLIGANDS TO SCREEN INHIBITORS OF AMYLOID-BETA PEPTIDE PRODUCTION | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000007995-A1 | SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-02-17 | — | — | WO | disclosed |
| US-5767281-A | Arthropodicidal oxazolines and thiazolines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-06-16 | — | — | US | disclosed |
| US-5686393-A | Arthropodicidal oxazolines and thiazolines | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0712394-A1 | ARTHROPODICIDAL OXAZOLINES AND THIAZOLINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-22 | — | — | EP | disclosed |
| WO-1995004726-A1 | ARTHROPODICIDAL OXAZOLINES AND THIAZOLINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12389794-B2 | Plurality of host materials and organic electroluminescent device comprising the same | TELO2, LIMS1, TERT | CYP2A6 3916/4885CYP1A2 3356/4885AGXT 3327/4885 |
| US-12435128-B2 | Method for predicting therapeutic effect of LSD1 inhibitor based on expression of INSM1 | INMT, CARM1, KDM1B | CYP2A6 3813/4885CYP1A2 1947/4885AGXT 3175/4885 |
| US-20070274922-A1 | Water Soluble Boronic Acid Fluorescent Reporter Compounds and Methods of Use Thereof | GUSB, BLVRB, BCL6 | CYP2A6 2321/4885CYP1A2 4275/4885AGXT 658/4885 |
| US-12441713-B2 | Organic compound and organic electroluminescent device comprising the same | ELAVL1, VDAC1, ELAVL3 | CYP2A6 3599/4885CYP1A2 1886/4885AGXT 1454/4885 |
| US-20250311628-A1 | PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | TELO2, LIMS1, TERT | CYP2A6 3916/4885CYP1A2 3356/4885AGXT 3327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.